Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency Read more
FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant Read more
Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers Read more
Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug Discovery Conference Read more
Book to attend the Parallel Trade conference before midnight Friday 28 th January and save £100 Read more
FDA Approves Veklury (Remdesivir) for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression Read more
FDA Approves Second Indication for SKYRIZI (risankizumab-rzaa) to Treat Adults with Active Psoriatic Arthritis Read more